AT332967B - Verfahren zur herstellung von adsorbierten vaccinen - Google Patents

Verfahren zur herstellung von adsorbierten vaccinen

Info

Publication number
AT332967B
AT332967B AT287173A AT287173A AT332967B AT 332967 B AT332967 B AT 332967B AT 287173 A AT287173 A AT 287173A AT 287173 A AT287173 A AT 287173A AT 332967 B AT332967 B AT 332967B
Authority
AT
Austria
Prior art keywords
manufacturing
adsorbed vaccines
vaccines
adsorbed
manufacturing adsorbed
Prior art date
Application number
AT287173A
Other languages
English (en)
Other versions
ATA287173A (de
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of ATA287173A publication Critical patent/ATA287173A/de
Application granted granted Critical
Publication of AT332967B publication Critical patent/AT332967B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT287173A 1972-04-06 1973-04-02 Verfahren zur herstellung von adsorbierten vaccinen AT332967B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7212036A FR2181426B1 (de) 1972-04-06 1972-04-06

Publications (2)

Publication Number Publication Date
ATA287173A ATA287173A (de) 1976-02-15
AT332967B true AT332967B (de) 1976-10-25

Family

ID=9096409

Family Applications (1)

Application Number Title Priority Date Filing Date
AT287173A AT332967B (de) 1972-04-06 1973-04-02 Verfahren zur herstellung von adsorbierten vaccinen

Country Status (13)

Country Link
US (1) US3925545A (de)
JP (1) JPS5549573B2 (de)
AT (1) AT332967B (de)
BE (1) BE797300A (de)
CA (1) CA1034496A (de)
CH (1) CH579630A5 (de)
DE (1) DE2316911C3 (de)
DK (1) DK143250C (de)
FR (1) FR2181426B1 (de)
GB (1) GB1422973A (de)
LU (1) LU67331A1 (de)
NL (1) NL7304219A (de)
YU (1) YU39706B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016252A (en) * 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
FR2502496A2 (fr) * 1981-03-30 1982-10-01 Pasteur Institut Fractions nouvelles extraites de bacteries aerobies, douees de proprietes antitumorales, antibacteriennes et inductrices d'interferon, et leur procede de preparation
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
FR2543439B1 (fr) * 1983-03-31 1985-09-27 Pasteur Institut Perfectionnement a la preparation d'un gel de phosphate de calcium utile a l'adsorption d'antigenes
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
US8728536B2 (en) 1996-10-16 2014-05-20 Etex Corporation Chemotherapeutic composition using nanocrystalline calcium phosphate paste
CA2361421A1 (en) 1999-02-03 2000-08-10 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles and methods of manufacture and use
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
JP5189763B2 (ja) 2003-04-11 2013-04-24 エテックス コーポレーション 骨誘導性骨材料
BRPI0507680A (pt) 2004-02-13 2007-07-17 Nod Pharmaceuticals Inc partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
WO2005117919A2 (en) 2004-04-15 2005-12-15 Etex Corporation Delayed-setting calcium phosphate pastes
WO2006050368A2 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
US8147860B2 (en) 2005-12-06 2012-04-03 Etex Corporation Porous calcium phosphate bone material
FR2912396B1 (fr) * 2007-02-09 2011-08-26 Solvay Procede de production d'un reactif phosphocalcique, reactif obtenu et son utilisation
KR102032002B1 (ko) 2011-11-23 2019-10-14 머크 샤프 앤드 돔 코포레이션 알루미늄 히드록시포스페이트 아주반트의 제조 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2364579A (en) * 1941-11-12 1944-12-05 Lederle Lab Inc Hog cholera vaccine
US3435112A (en) * 1966-06-21 1969-03-25 Norden Lab Inc Repository vaccine and method of preparing the same
FR1604134A (de) * 1967-09-26 1971-07-12

Also Published As

Publication number Publication date
LU67331A1 (de) 1973-06-15
YU39706B (en) 1985-04-30
DE2316911C3 (de) 1980-06-12
DE2316911B2 (de) 1979-03-15
FR2181426A1 (de) 1973-12-07
NL7304219A (de) 1973-10-09
GB1422973A (en) 1976-01-28
DK143250B (da) 1981-08-03
CH579630A5 (de) 1976-09-15
ATA287173A (de) 1976-02-15
DE2316911A1 (de) 1973-10-25
CA1034496A (en) 1978-07-11
US3925545A (en) 1975-12-09
YU93473A (en) 1982-02-28
JPS4913322A (de) 1974-02-05
FR2181426B1 (de) 1974-12-20
BE797300A (fr) 1973-09-26
JPS5549573B2 (de) 1980-12-12
DK143250C (da) 1981-12-14

Similar Documents

Publication Publication Date Title
AT326270B (de) Verfahren zur herstellung von arzneiformen
AT333580B (de) Verfahren zur herstellung von kunstlichen fruchten
AT345152B (de) Verfahren zur herstellung von formkoerpern
AT332967B (de) Verfahren zur herstellung von adsorbierten vaccinen
ATA148273A (de) Verfahren zur herstellung wasserunloslicher kapseln
AT330740B (de) Verfahren zur herstellung von neuensulfonamidodiphenylathern
AT322838B (de) Verfahren zur herstellung von poly-alfa-olefinen
ATA770674A (de) Verfahren zur herstellung von neuen penicillinen
AT341640B (de) Verfahren zur herstellung von dickstellengarnen
AT328420B (de) Verfahren zur herstellung von hydrazonen
AT332543B (de) Verfahren zur herstellung von antibiotika
AT325767B (de) Verfahren zur herstellung von neuen penicillinen
AT329177B (de) Verfahren zur herstellung von neuen penicillinen
AT325774B (de) Verfahren zur herstellung von neuen penicillinen
AT326268B (de) Verfahren zur herstellung von neuen penicillinen
AT324193B (de) Verfahren zur herstellung von schleifscheiben
AT320627B (de) Verfahren zur Herstellung von α-Deoxytetracyclinen
AT341686B (de) Verfahren zur herstellung von vincamon und vincanol
AT324561B (de) Verfahren zur herstellung von neuen penicillinen
AT327412B (de) Verfahren zur herstellung von prostaglandinen
CH552030A (de) Verfahren zur herstellung von pyranthronen.
AT321924B (de) Verfahren zur herstellung von 1-hydrazino-phthalazin-hydrochlorid
ATA300474A (de) Verfahren zur herstellung von diolefinen
AT302220B (de) Verfahren zur herstellung von zearalenon
ATA527672A (de) Verfahren zur herstellung von konjakumannan

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee